Pharmaceutical Access and the Human Right to Science
DOI:
https://doi.org/10.52609/jmlph.v5i4.225Keywords:
Access to Medicine, Health Rights, Medicine Shortages, Right to Science, Socio-economic RightsAbstract
Access to medicines is a pertinent human rights issue: inadequate access to necessary medications poses severe consequences, including preventable deaths. The right of access to medicines is recognised as a fundamental aspect of the right to health, which is widely integrated into international and domestic legal systems. A right that has received less attention, however, is the right to benefit from scientific progress and its applications (hereinafter referred to as ‘the right to science’). This is a long-standing right, but has only recently begun to draw attention in the discourse on human rights. There is an interdependence between the two aforementioned rights, primarily in that science is required for the research and development of medicines. Thus it can be argued that, without the right to science, the right to medicines cannot be fully realised. This inquiry lays the foundation for further exploration of the utility of the right to science in alleviating prominent global issues such as inadequate access to medicines.
References
Table of Cases
Lopez, Glenda, et al. v Instituto Venezolano de los Seguros Sociales https://www.escr-net.org/es/caselaw/2006/lopez-glenda-y-otros-c-instituto-venezolano-seguros-sociales-ivss-s-accion-amparo/ (Accessed 10 January 2025).
Table of Journals
Ahmadiani S and Nikfar S, ‘Challenges of Access to Medicine and the Responsibility of Pharma-ceutical Companies: A Legal Perspective’ (2016) 24 DARU Journal of Pharmaceutical Sciences.
Boggio A, ‘The Right to Participate in and Enjoy the Benefits of Scientific Progress and Its Ap-plications: A Conceptual Map’ (2022) 34 Bry-ant University, Bryant Digital Repository 43.
Chirwa DM, ‘The right to health in international law: Its implications for the obligations of state and non-state actors in ensuring access to essential medicine’ (2003) 19(4) South African Journal on Human Rights 541–566.
Donders Y, ‘The Right to Enjoy the Benefits of Scientific Progress: In Search of State Obliga-tions in Relation to Health’ (2011) 14 Medi-cine, Health Care and Philosophy 371.
Hendriks A, ‘The Right to Health’ (1994) 1 Euro-pean Journal of Health Law 187.
Jamar SD, ‘The International Human Right to Health’ (1994) 22 Southern University Law Review 1 <https://ssrn.com/abstract=1093085>.
Müller A, ‘Remarks on the Venice Statement on the Right to Enjoy the Benefits of Scientific Progress and its Applications (Article 15(1)(b) ICESCR)’ (2010) 10 Human Rights Law Re-view 765 <https://doi.org/10.1093/hrlr/ngq033>.
Ozawa S, Shankar R, Leopold C and Orubu S, ‘Access to Medicines through Health Systems in Low- and Middle-Income Countries’ (2019) 34 Health Policy and Planning <https://doi.org/10.1093/heapol/czz119>.
Shawa R, Ahmed R, Bawa M and Kapumba B, ‘A Promising Potential: Using the Right to En-joy the Benefits of Scientific Progress to Ad-vance Public Health in South Africa’ (2023) 23 African Human Rights Law Journal 30.
Smith T, ‘Understanding the Nature and Scope of the Right to Science through the Travaux Préparatoires of the Universal Declaration of Human Rights and the International Covenant on Economic, Social and Cultural Rights’ (2020) 24 International Journal of Human Rights 1156 <https://doi.org/10.1080/13642987.2020.1715947>.
Tiberi S, Carvalho ACC, Sulis G and others, ‘The Challenge of the New Tuberculosis Drugs’ (2017) 46 La Presse Médicale e41 <https://doi.org/10.1016/j.lpm.2017.01.016>.
Table of Books
De Schutter O, 'The Status of Human Rights in International Law' in Catarina Krause and Martin Scheinin (eds), International Protection of Human Rights: A Textbook (2nd edn, Åbo Akademi University Institute for Human Rights 2012) 39
Hannum H, 'The United Nations and Human Rights' in Catarina Krause and Martin Schein-in (eds), International Protection of Human Rights: A Textbook (2nd edn, Åbo Akademi University Institute for Human Rights 2012) 149
Riedel E, 'Economic, Social and Cultural Rights' in Catarina Krause and Martin Scheinin (eds), International Protection of Human Rights: A Textbook (2nd edn, Åbo Akademi University Institute for Human Rights 2012) 377
Saul B and others, The International Covenant on Economic, Social and Cultural Rights: Com-mentary, Cases, and Materials (OUP 2014)
Ssenyonjo M, Economic, Social and Cultural Rights in International Law (Hart Publishing 2009)
Tobin J, The Right to Health in International Law (OUP 2012)
Toebes B, The Right to Health as a Human Right in International Law (Intersentia 1999)
Other Cited Materials
Australian Medical Association, ‘New forum needed to improve Australia’s response to medicine shortages’ (24 January 2025) <https://www.ama.com.au/media/new-forum-needed-improve-australias-response-medicine-shortages> accessed 10 May 2025.
Coomber P, ‘Why doesn’t Australia make more medicines? Wouldn’t that fix drug shortages?’ (12 May 2025) <https://www.uq.edu.au/news/article/2025/05/why-doesnt-australia-make-more-medicines-wouldnt-fix-drug-shortages> accessed 14 May 2025.
Health Justice Initiative, ‘Joint statement in re-sponse to South African Competition Com-mission decision to drop investigation against Vertex Pharmaceuticals on treatment for cystic fibrosis’ (13 December 2024) <https://healthjusticeinitiative.org.za/2024/12/13/joint-statement-competition-commission-vertex-south-africa/> accessed 10 January 2025.
Mousavi SMR, ‘Iran’s dire and growing drug shortage’ (10 October 2025) <https://www.stimson.org/2025/irans-dire-and-growing-drug-shortage/> accessed 27 February 2025.
Tehran Times, ‘Civil society activists warn about US threats against Iran’ (6 September 2025) <https://www.tehrantimes.com/news/511498/Civil-society-activists-warn-about-US-threats-against-Iran> accessed 10 April 2025.
Time News, ‘Ministry of Health and Invima, sued for lack of medicines’ (2024) <https://time.news/ministry-of-health-and-invima-sued-for-lack-of-medicines/> accessed 10 January 2025.
UN Special Rapporteur in the Field of Cultural Rights, Report of the Special Rapporteur in the Field of Cultural Rights, Farida Shaheed: The right to enjoy the benefits of scientific progress and its applications (A/HRC/20/26, 10 May 2012) <https://digitallibrary.un.org/record/730844> accessed 12 September 2025.
World Health Assembly, Addressing the global shortage of medicines and vaccines (WHA69.25, 28 May 2016) <https://apps.who.int/gb/ebwha/pdf_files/WHA69/A69_R25-en.pdf>.
World Health Organization, ‘Access to medicines: making market forces serve the poor’ in Ten years in public health, 2007–2017: Report by Dr Margaret Chan, Director-General (2017) <https://www.who.int/publications/i/item/9789241512442> accessed 23 July 2019.
World Health Organization, The first ten years of the World Health Organization (1958) <https://www.who.int/publications/i/item/9789241560146>.
World Health Organization, ‘Medicines’ (Health Topics webpage, last updated 5 September 2025) <https://www.who.int/health-topics/medicines> accessed 10 April 2025.
World Health Organization, WHO model list of essential medicines (23rd list, 2023) <https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2023.02> accessed 10 April 2025.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Michelle Brotherton
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Creative Commons Attribution 4.0 International License (CC BY 4.0) is a flexible and commonly used license that allows others to share, remix, adapt, and build upon the work even for commercial purposes, as long as they follow the requirements outlined by the license.
